Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Virology|February 2, 2010
Avian influenza viral nucleocapsid and hemagglutinin proteins induce chicken CD8+ memory T lymphocytesShailbala Singh, Worthie E Briles, Blanca Lupiani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
B cell depletion promotes melanoma tumor growth in a CD4+ T cell-dependent mannerSelin Oncul, Hani Lee, Shailbala Singh, et al.
Vaccines|December 7, 2017
Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in MiceArshad Khan, Shailbala Singh, Gloria Galvan, et al.
Journal for Immunotherapy of Cancer|January 25, 2025
Urine proteomics defines an immune checkpoint-associated nephritis signatureJames P Long, Shailbala Singh, Yanlan Dong, et al.
Plos One|March 7, 2014
Sublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challengeShailbala Singh, Guojun Yang, Kimberly S Schluns, et al.
Vaccine|December 3, 2014
Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope proteinShailbala Singh, Guojun Yang, Siddappa N Byrareddy, et al.
Journal for Immunotherapy of Cancer|April 30, 2026
First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case studyCasey Bermack, Shailbala Singh, Guangsheng Pei, et al.
JCI Insight|December 6, 2022
Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritisShailbala Singh, James P Long, Amanda Tchakarov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2020
Mucoadhesive wafers composed of binary polymer blends for sublingual delivery and preservation of protein vaccinesSamuel M Hanson, Shailbala Singh, Anthony Tabet, et al.
European Journal of Immunology|August 6, 2011
Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lungAmy N Courtney, Prakash Thapa, Shailbala Singh, et al.
Pageof 4